Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 15 (RPS2P15) is one of several processed pseudogenes derived from the functional ribosomal protein S2 (RPS2) gene, which encodes a component of the 40S ribosomal subunit involved in protein synthesis[6][7][9]. Pseudogenes like RPS2P15 are highly homologous to the functional gene but are considered non-coding due to structural changes within their DNA sequences that prevent proper expression or function[7][9]. These pseudogenes are widespread in the human genome, typically resulting from duplication and retrotransposition events, and are not known to play direct roles in molecular biology or pharmacology[7][9].\nKey distinctions: - RPS2 (ribosomal protein S2) is a bona fide protein-coding gene with important cellular functions.\n- RPS2P15 is a pseudogene, meaning it does not encode a functional protein nor serve as a therapeutic target.\nTherefore, RPS2P15 should not be confused with the functional ribosomal protein S2 and is not considered a valid therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 15 (RPS2P15).